This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Stryka-516

StrykaGen

Drug Names(s): Stryka516, Stryke 516

Description: Stryka-516 is a small molecule therapeutic that increases alpha7beta1 integrin in muscle cells. The company knows the likely direct mechanism, which involves several molecular targets, but is not yet disclosing it.


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug